Financials ONCS BRAS

Equities

ONCO3

BRONCOACNOR6

Market Closed - Sao Paulo 21:11:00 22/05/2024 BST 5-day change 1st Jan Change
7.45 BRL -9.37% Intraday chart for ONCS BRAS +24.58% -42.69%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 5,254 2,889 6,603 4,178 - -
Enterprise Value (EV) 1 5,364 6,100 10,607 8,546 8,153 8,387
P/E ratio -98.7 x 69.3 x - 15.7 x 8.88 x 8.69 x
Yield - - - 2.82% 1.95% -
Capitalization / Revenue 1.94 x 0.71 x 1.2 x 0.64 x 0.55 x 0.5 x
EV / Revenue 1.99 x 1.49 x 1.93 x 1.31 x 1.08 x 0.99 x
EV / EBITDA 11.1 x 7.96 x 9.35 x 6.61 x 5.25 x 5.01 x
EV / FCF -25.4 x -10.6 x - -68.4 x 9.69 x 7.75 x
FCF Yield -3.94% -9.44% - -1.46% 10.3% 12.9%
Price to Book 2.88 x 1.36 x - 1.47 x 1.39 x -
Nbr of stocks (in thousands) 466,986 479,114 507,910 508,285 - -
Reference price 2 11.25 6.030 13.00 7.450 7.450 7.450
Announcement Date 29/03/22 28/03/23 27/03/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,035 2,702 4,088 5,489 6,548 7,575 8,433
EBITDA 1 - 481.1 766.2 1,134 1,293 1,552 1,674
EBIT 1 - 177.2 470.6 758 1,019 1,224 1,421
Operating Margin - 6.56% 11.51% 13.81% 15.56% 16.15% 16.85%
Earnings before Tax (EBT) 1 - 62.3 121.5 302.5 295 793.9 660
Net income 1 -38.54 -22.4 46.26 312.6 315 464.6 435.6
Net margin -1.89% -0.83% 1.13% 5.7% 4.81% 6.13% 5.17%
EPS 2 - -0.1140 0.0870 - 0.4739 0.8390 0.8570
Free Cash Flow 1 - -211.2 -575.8 - -125 841.5 1,082
FCF margin - -7.82% -14.08% - -1.91% 11.11% 12.84%
FCF Conversion (EBITDA) - - - - - 54.24% 64.66%
FCF Conversion (Net income) - - - - - 181.14% 248.49%
Dividend per Share 2 - - - - 0.2100 0.1450 -
Announcement Date 26/03/21 29/03/22 28/03/23 27/03/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 679.4 767.9 808 899.9 1,164 1,216 1,294 1,360 1,402 1,434 1,459 1,613 1,682 1,720
EBITDA 1 117.6 140 141.3 158.9 213 253.1 291.7 285.4 285.4 271.7 254.4 337.1 329.3 330.5
EBIT 1 196.3 73.1 - 76 131.1 190.9 - 187.6 184 177.7 166.8 258.8 250.7 245.6
Operating Margin 28.89% 9.52% - 8.45% 11.26% 15.69% - 13.8% 13.13% 12.39% 11.43% 16.04% 14.9% 14.27%
Earnings before Tax (EBT) - - - - 34.9 65.1 - 70.49 - 119.1 - - - -
Net income 1 - - - - 30.8 71.11 - 21.01 105 87 19.6 - - -
Net margin - - - - 2.65% 5.85% - 1.55% 7.49% 6.07% 1.34% - - -
EPS 2 0.3614 0.0374 -0.0484 -0.0700 0.0649 0.1389 0.0400 0.0398 - - 0.0349 0.0768 0.1286 0.1477
Dividend per Share 2 - - - - - - - - - - - - - -
Announcement Date 16/11/21 29/03/22 16/05/22 15/08/22 10/11/22 28/03/23 15/05/23 14/08/23 13/11/23 27/03/24 13/05/24 - - -
1BRL in Million2BRL
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 110 3,211 4,004 4,368 3,975 4,209
Net Cash position 1 - - - - - - -
Leverage (Debt/EBITDA) - 0.2289 x 4.191 x 3.531 x 3.378 x 2.562 x 2.514 x
Free Cash Flow 1 - -211 -576 - -125 842 1,083
ROE (net income / shareholders' equity) - -0.99% 2.33% 14.1% 7.92% 14.4% 17%
ROA (Net income/ Total Assets) - -0.48% 0.65% 3.59% 1.51% 2.77% 3.41%
Assets 1 - 4,713 7,126 8,700 20,831 16,795 12,775
Book Value Per Share 2 - 3.900 4.430 - 5.070 5.350 -
Cash Flow per Share - - - - - - -
Capex 1 - 202 304 - 608 312 364
Capex / Sales - 7.47% 7.44% - 9.29% 4.12% 4.32%
Announcement Date 26/03/21 29/03/22 28/03/23 27/03/24 - - -
1BRL in Million2BRL
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
7.45 BRL
Average target price
14.06 BRL
Spread / Average Target
+88.76%
Consensus